Vericel Corporation Common Stock (VCEL)
Stock · NASDAQ · Health Care
$40.95as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$33.66
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
About VCEL
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Website
- vcel.com/
Fundamentals
- Market cap
- $2.29B
- P/E (trailing)
- 93.45
- P/E (forward)
- —
- EPS (trailing)
- $0.42
- Dividend yield
- —
- Beta
- 1.04
- Avg. volume
- —
52-week range
$28.95$49.32
How Vericel Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Vericel Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- VCELVericel Corporation Common Stock$40.95▼ 0.56%Market cap $2.29BP/E 93.45$28.95$49.32
- COAGHemab Therapeutics Holdings Inc. Common Stock$44.77▼ 9.55%Market cap $2.44BP/E —$23$55.42
- MESOMesoblast Limited American Depositary Shares$17.42▼ 4.18%Market cap $2.02BP/E —$1.88$3.31
- TARSTarsus Pharmaceuticals Inc. Common Stock$71.84▼ 0.12%Market cap $2.81BP/E —$48.2$85.25
- BEAMBeam Therapeutics Inc. Common Stock$29.31▼ 3.84%Market cap $2.81BP/E —$16.02$38.26
- KODKodiak Sciences Inc Common Stock$37.77▼ 3.45%Market cap $2.84BP/E —$8.29$47.84
- RXRXRecursion Pharmaceuticals Inc. Class A Common Stock$3.33▼ 3.20%Market cap $1.69BP/E —$2.77$7.18
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| VCEL Vericel Corporation Common Stock | $2.29B | 93.45 | $40.95 | ▼ 0.56% | $28.95$49.32 |
| COAG Hemab Therapeutics Holdings Inc. Common Stock | $2.44B | — | $44.77 | ▼ 9.55% | $23$55.42 |
| MESO Mesoblast Limited American Depositary Shares | $2.02B | — | $17.42 | ▼ 4.18% | $1.88$3.31 |
| TARS Tarsus Pharmaceuticals Inc. Common Stock | $2.81B | — | $71.84 | ▼ 0.12% | $48.2$85.25 |
| BEAM Beam Therapeutics Inc. Common Stock | $2.81B | — | $29.31 | ▼ 3.84% | $16.02$38.26 |
| KOD Kodiak Sciences Inc Common Stock | $2.84B | — | $37.77 | ▼ 3.45% | $8.29$47.84 |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | $1.69B | — | $3.33 | ▼ 3.20% | $2.77$7.18 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 55.60M
- Total value held
- $1.71B
- Institutional holders
- 271
Top holders this quarter
- Unknown7.77M
- Unknown3.15M
- Unknown2.55M
- Unknown2.46M
- Unknown2.23M
- Unknown1.96M
- Unknown1.83M
- Unknown1.72M
- Unknown1.65M
- Unknown1.62M
See the full, filterable feed with live charts on the MarketWall dashboard.